Literature DB >> 20951730

Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

George R Breese1, Rajita Sinha, Markus Heilig.   

Abstract

Alcoholism is a chronic relapsing disorder. Major characteristics observed in alcoholics during an initial period of alcohol abstinence are altered physiological functions and a negative emotional state. Evidence suggests that a persistent, cumulative adaptation involving a kindling/allostasis-like process occurs during the course of repeated chronic alcohol exposures that is critical for the negative symptoms observed during alcohol withdrawal. Basic studies have provided evidence for specific neurotransmitters within identified brain sites being responsible for the negative emotion induced by the persistent cumulative adaptation following intermittent-alcohol exposures. After an extended period of abstinence, the cumulative alcohol adaptation increases susceptibility to stress- and alcohol cue-induced negative symptoms and alcohol seeking, both of which can facilitate excessive ingestion of alcohol. In the alcoholic, stressful imagery and alcohol cues alter physiological responses, enhance negative emotion, and induce craving. Brain fMRI imaging following stress and alcohol cues has documented neural changes in specific brain regions of alcoholics not observed in social drinkers. Such altered activity in brain of abstinent alcoholics to stress and alcohol cues is consistent with a continuing ethanol adaptation being responsible. Therapies in alcoholics found to block responses to stress and alcohol cues would presumably be potential treatments by which susceptibility for continued alcohol abuse can be reduced. By continuing to define the neurobiological basis of the sustained alcohol adaptation critical for the increased susceptibility of alcoholics to stress and alcohol cues that facilitate craving, a new era is expected to evolve in which the high rate of relapse in alcoholism is minimized. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20951730      PMCID: PMC3026093          DOI: 10.1016/j.pharmthera.2010.09.007

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  321 in total

1.  Development of an alcohol deprivation and escalation effect in C57BL/6J mice.

Authors:  Roberto I Melendez; Lawrence D Middaugh; Peter W Kalivas
Journal:  Alcohol Clin Exp Res       Date:  2006-12       Impact factor: 3.455

Review 2.  The familial incidence of alcoholism: a review.

Authors:  N S Cotton
Journal:  J Stud Alcohol       Date:  1979

3.  Dissociation between physical dependence and volitional ethanol consumption: role of multiple withdrawal episodes.

Authors:  B E Hunter; D W Walker; J N Riley
Journal:  Pharmacol Biochem Behav       Date:  1974 Jul-Aug       Impact factor: 3.533

4.  Development of an alcohol-deprivation effect in rats.

Authors:  J D Sinclair; R J Senter
Journal:  Q J Stud Alcohol       Date:  1968-12

5.  Excessive ethanol drinking following a history of dependence: animal model of allostasis.

Authors:  A J Roberts; C J Heyser; M Cole; P Griffin; G F Koob
Journal:  Neuropsychopharmacology       Date:  2000-06       Impact factor: 7.853

Review 6.  Alcoholism: allostasis and beyond.

Authors:  George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2003-02       Impact factor: 3.455

7.  The kindling hypothesis: further evidence from a U.S. national study of alcoholic men.

Authors:  B M Booth; F C Blow
Journal:  Alcohol Alcohol       Date:  1993-09       Impact factor: 2.826

8.  Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence.

Authors:  Marisa Roberto; Maureen T Cruz; Nicholas W Gilpin; Valentina Sabino; Paul Schweitzer; Michal Bajo; Pietro Cottone; Samuel G Madamba; David G Stouffer; Eric P Zorrilla; George F Koob; George R Siggins; Loren H Parsons
Journal:  Biol Psychiatry       Date:  2010-01-08       Impact factor: 13.382

9.  A role for corticotropin releasing factor (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice.

Authors:  M Foster Olive; Kristin K Mehmert; Heather N Koenig; Rosana Camarini; Joseph A Kim; Michelle A Nannini; Christine J Ou; Clyde W Hodge
Journal:  Psychopharmacology (Berl)       Date:  2002-10-24       Impact factor: 4.530

10.  Electrical amygdala kindling in alcohol-withdrawal kindled rats.

Authors:  J Ulrichsen; D P Woldbye; T M Madsen; L Clemmesen; S Haugbøl; C H Olsen; H Laursen; T G Bolwig; R Hemmingsen
Journal:  Alcohol Alcohol       Date:  1998 May-Jun       Impact factor: 2.826

View more
  118 in total

1.  Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol.

Authors:  Lara S Hwa; Adam Chu; Sally A Levinson; Tala M Kayyali; Joseph F DeBold; Klaus A Miczek
Journal:  Alcohol Clin Exp Res       Date:  2011-06-01       Impact factor: 3.455

2.  Alcohol stress response dampening: selective reduction of anxiety in the face of uncertain threat.

Authors:  Kathryn R Hefner; John J Curtin
Journal:  J Psychopharmacol       Date:  2011-09-21       Impact factor: 4.153

Review 3.  Retraining the addicted brain: a review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention.

Authors:  Katie Witkiewitz; M Kathleen B Lustyk; Sarah Bowen
Journal:  Psychol Addict Behav       Date:  2012-07-09

Review 4.  [Oxytocin and the mechanisms of alcohol dependence].

Authors:  Till Faehrmann; Gerald Zernig; Sergei Mechtcheriakov
Journal:  Neuropsychiatr       Date:  2017-06-21

Review 5.  Vasopressin and alcohol: a multifaceted relationship.

Authors:  Kathryn M Harper; Darin J Knapp; Hugh E Criswell; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2018-11-03       Impact factor: 4.530

6.  Mindfulness-based relapse prevention for substance craving.

Authors:  Katie Witkiewitz; Sarah Bowen; Haley Douglas; Sharon H Hsu
Journal:  Addict Behav       Date:  2012-04-06       Impact factor: 3.913

7.  Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice.

Authors:  Eric W Fish; Abigail E Agoglia; Michael C Krouse; R Grant Muller; J Elliott Robinson; C J Malanga
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

Review 8.  Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Signaling and the Dark Side of Addiction.

Authors:  Olivia W Miles; Victor May; Sayamwong E Hammack
Journal:  J Mol Neurosci       Date:  2018-08-03       Impact factor: 3.444

9.  Chronic Intermittent Ethanol Exposure Selectively Increases Synaptic Excitability in the Ventral Domain of the Rat Hippocampus.

Authors:  Sarah E Ewin; James W Morgan; Farr Niere; Nate P McMullen; Samuel H Barth; Antoine G Almonte; Kimberly F Raab-Graham; Jeffrey L Weiner
Journal:  Neuroscience       Date:  2018-11-24       Impact factor: 3.590

10.  β1-adrenoceptor activation is required for ethanol enhancement of lateral paracapsular GABAergic synapses in the rat basolateral amygdala.

Authors:  Yuval Silberman; Olusegun J Ariwodola; Jeff L Weiner
Journal:  J Pharmacol Exp Ther       Date:  2012-08-17       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.